Corpus Intelligence IC Memo — WOOD COUNTY HOSPITAL 2026-04-26 13:27 UTC
IC Memo — WOOD COUNTY HOSPITAL
Investment Committee Memorandum | OH | 99 beds | Grade C | EBITDA uplift $7.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WOOD COUNTY HOSPITAL

CCN 360029 | WOOD, OH | 99 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WOOD COUNTY HOSPITAL is a 99-bed suburban community hospital in WOOD, OH with $105.9M in net patient revenue and a 0.2% operating margin. The hospital serves a payer mix of 24.9% Medicare, 2.5% Medicaid, and 72.6% commercial.

Thesis: Turnaround. Our ML models identify $7.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.2% to 7.6% (+736bps).

Net Revenue HCRIS$105.9M
Current EBITDA COMPUTED$224K
Operating Margin COMPUTED0.2%
Occupancy HCRIS17.8%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS44.2%
Distress Probability ML56.8%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
105
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 0.2% places it above the state median. Among 105 size-comparable peers (50-198 beds), the median margin is 1.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (50-198), prioritizing same-state peers. 105 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WOOD COUNTY HOSPITAL (Target)OH99$105.9M0.2%
DAYTON CHILDRENS HOSPITALOH181$569.1M7.9%
MARIETTA MEMORIAL HOSPITALOH188$475.8M-12.4%
SOUTHERN OHIO MEDICAL CENTEROH192$424.3M-4.9%
SOUTHWEST GENERAL HEALTH CENTEOH191$406.9M2.5%
MARION GENERAL HOSPITALOH177$365.7M35.5%
DUBLIN METHODIST HOSPITALOH110$333.9M28.4%
JEWISH HOSPITAL OF CINCINNATIOH170$333.6M-5.9%
WEST CHESTER HOSPITAL LLCOH163$318.7M-12.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.2M+210bp18mo
Cost to Collect4.5%2.5%$2.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.3M+122bp9mo
Clean Claim Rate88.0%96.0%$68K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.2M
Cost to Collect
$2.1M
Denial Rate Reduction
$2.1M
A/R Days Reduction
$1.3M
Clean Claim Rate
$68K
Total EBITDA Uplift$7.8M
Current EBITDA$224K
+ RCM Uplift+$7.8M
Pro Forma EBITDA$8.0M
Current Margin0.2%
Pro Forma Margin7.6%
WC Released (1x)$4.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$345K$79.5M230.52x196.8%
Base (11x exit)10.0x11.0x$345K$87.5M253.90x202.6%
Bull Case9.0x11.0x$310K$113.4M365.42x225.5%
Bull (12x exit)9.0x12.0x$310K$123.8M398.93x231.3%
Bear Case11.0x10.0x$379K$40.4M106.43x154.3%
Bear (11x exit)11.0x11.0x$379K$44.5M117.40x159.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 17.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 56.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 105 hospitals with 50-198 beds
  • Same-state prioritization (n=106)
  • Comp margins: P25=-12.9% / P50=1.4% / P75=8.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.